{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:31:51Z","timestamp":1789248711307,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC-2024-2790372"],"award-info":[{"award-number":["RC-2024-2790372"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007385","name":"Fondazione Cassa di Risparmio di Bologna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41409-024-02489-8","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:05:02Z","timestamp":1733828702000},"page":"346-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The EASIX score as a predictor of sinusoidal obstruction syndrome and nonrelapse mortality in paediatric patients receiving allogeneic haematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-3140","authenticated-orcid":false,"given":"Edoardo","family":"Muratore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Gambuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-5876","authenticated-orcid":false,"given":"Davide","family":"Leardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8313-7288","authenticated-orcid":false,"given":"Francesco","family":"Baccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Venturelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyna","family":"Larcinese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gottardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Di Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Belotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"2489_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.blre.2018.11.001","volume":"34","author":"EA Copelan","year":"2019","unstructured":"Copelan EA, Chojecki A, Lazarus HM, Avalos BR. Allogeneic hematopoietic cell transplantation; the current renaissance. Blood Rev. 2019;34:34\u201344.","journal-title":"Blood Rev"},{"key":"2489_CR2","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00277-022-04965-x","volume":"101","author":"R Masetti","year":"2022","unstructured":"Masetti R, Muratore E, Gori D, Prete A, Locatelli F. Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis. Ann Hematol. 2022;101:2497\u2013506.","journal-title":"Ann Hematol"},{"key":"2489_CR3","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.3390\/jcm10173790","volume":"10","author":"M Algeri","year":"2021","unstructured":"Algeri M, Merli P, Locatelli F, Pagliara D. The role of allogeneic hematopoietic stem cell transplantation in pediatric leukemia. J Clin Med. 2021;10:3790.","journal-title":"J Clin Med"},{"key":"2489_CR4","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3324\/haematol.2020.253716","volume":"106","author":"S Cordes","year":"2021","unstructured":"Cordes S, Mokhtari Z, Bartosova M, Mertlitz S, Riesner K, Shi Y, et al. Endothelial damage and dysfunction in acute graft-versus-host disease. Haematologica. 2021;106:2147\u201360.","journal-title":"Haematologica"},{"key":"2489_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","volume":"22","author":"J-H Dalle","year":"2016","unstructured":"Dalle J-H, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transpl. 2016;22:400\u20139.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2489_CR6","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/jcm11030623","volume":"11","author":"G Milone","year":"2022","unstructured":"Milone G, Bellofiore C, Leotta S, Milone GA, Cupri A, Duminuco A, et al. Endothelial dysfunction after hematopoietic stem cell transplantation: a review based on physiopathology. J Clin Med. 2022;11:623.","journal-title":"J Clin Med"},{"key":"2489_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-93571-4","volume":"11","author":"R Masetti","year":"2021","unstructured":"Masetti R, Biagi E, Zama D, Muratore E, D\u2019Amico F, Leardini D, et al. Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Sci Rep. 2021;11:1\u201311.","journal-title":"Sci Rep"},{"key":"2489_CR8","doi-asserted-by":"publisher","first-page":"580.e1","DOI":"10.1016\/j.jtct.2024.03.026","volume":"30","author":"M Farina","year":"2024","unstructured":"Farina M, Scaini MC, Facchinetti A, Leoni A, Bernardi S, Catoni C, et al. Evaluation of circulating endothelial cells as direct marker of endothelial damage in allo-transplant recipients at high risk of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome. Transpl Cell Ther. 2024;30:580.e1\u201314.","journal-title":"Transpl Cell Ther"},{"key":"2489_CR9","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/S2352-3026(17)30108-4","volume":"4","author":"T Luft","year":"2017","unstructured":"Luft T, Benner A, Jodele S, Dandoy CE, Storb R, Gooley T, et al. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol. 2017;4:e414\u201323.","journal-title":"Lancet Haematol"},{"key":"2489_CR10","doi-asserted-by":"publisher","first-page":"187.e1","DOI":"10.1016\/j.jtct.2023.11.016","volume":"30","author":"A Pedraza","year":"2024","unstructured":"Pedraza A, Salas MQ, Rodr\u00edguez-Lobato LG, Escribano-Serrat S, Su\u00e1rez-Lledo M, Mart\u00ednez-Cebrian N, et al. Easix score correlates with endothelial dysfunction biomarkers and predicts risk of acute graft-versus-host disease after allogeneic transplantation. Transpl Cell Ther. 2024;30:187.e1\u201312.","journal-title":"Transpl Cell Ther"},{"key":"2489_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00134-022-06676-3","volume":"48","author":"F Korell","year":"2022","unstructured":"Korell F, Schreck N, M\u00fcller-Tidow C, Dreger P, Luft T, the Taskforce allogeneic Stem Cell Transplantation, University Hospital Heidelberg. et al. Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation. Intensive Care Med. 2022;48:753\u20135.","journal-title":"Intensive Care Med"},{"key":"2489_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3324\/haematol.2019.238790","volume":"106","author":"S Jiang","year":"2021","unstructured":"Jiang S, Penack O, Terzer T, Schult D, Majer-Lauterbach J, Radujkovic A, et al. Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel. Haematologica. 2021;106:446\u201353.","journal-title":"Haematologica"},{"key":"2489_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41409-019-0703-1","volume":"55","author":"T Luft","year":"2020","unstructured":"Luft T, Benner A, Terzer T, Jodele S, Dandoy CE, Storb R, et al. EASIX and mortality after allogeneic stem cell transplantation. Bone Marrow Transpl. 2020;55:553\u201361.","journal-title":"Bone Marrow Transpl"},{"key":"2489_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41409-022-01874-5","volume":"58","author":"J Mariotti","year":"2023","unstructured":"Mariotti J, Magri F, Giordano L, De Philippis C, Sarina B, Mannina D, et al. EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide. Bone Marrow Transpl. 2023;58:247\u201356.","journal-title":"Bone Marrow Transpl"},{"key":"2489_CR15","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1182\/bloodadvances.2022007381","volume":"6","author":"MT Nawas","year":"2022","unstructured":"Nawas MT, Sanchez-Escamilla M, Devlin SM, Maloy MA, Ruiz JD, Sauter CS, et al. Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2022;6:5898\u2013907.","journal-title":"Blood Adv"},{"key":"2489_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41409-023-01922-8","volume":"58","author":"M Sanchez-Escamilla","year":"2023","unstructured":"Sanchez-Escamilla M, Flynn J, Devlin S, Maloy M, Fatmi SA, Tomas AA, et al. EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2023;58:498\u2013505.","journal-title":"Bone Marrow Transpl"},{"key":"2489_CR17","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1182\/bloodadvances.2021004812","volume":"5","author":"M Pe\u00f1a","year":"2021","unstructured":"Pe\u00f1a M, Salas MQ, Mussetti A, Moreno-Gonzalez G, Bosch A, Pati\u00f1o B, et al. Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation. Blood Adv. 2021;5:3418\u201326.","journal-title":"Blood Adv"},{"key":"2489_CR18","doi-asserted-by":"publisher","first-page":"580.e1","DOI":"10.1016\/j.jtct.2023.06.021","volume":"29","author":"S Fujita","year":"2023","unstructured":"Fujita S, Monna-Oiwa M, Kato S, Isobe M, Takahashi S, Nannya Y, et al. Pretransplantation EASIX score predicts nonrelapse and overall mortality of adult patients undergoing single-unit unrelated cord blood transplantation. Transpl Cell Ther. 2023;29:580.e1\u20138.","journal-title":"Transpl Cell Ther"},{"key":"2489_CR19","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2489_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","volume":"53","author":"S Corbacioglu","year":"2018","unstructured":"Corbacioglu S, Carreras E, Ansari M, Balduzzi A, Cesaro S, Dalle J-H, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transpl. 2018;53:138\u201345.","journal-title":"Bone Marrow Transpl"},{"key":"2489_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295\u2013304.","journal-title":"Transplantation"},{"key":"2489_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/bjc.1982.83","volume":"45","author":"MK Palmer","year":"1982","unstructured":"Palmer MK. WHO handbook for reporting results of cancer treatment. Br J Cancer. 1982;45:484\u20135.","journal-title":"Br J Cancer"},{"key":"2489_CR23","doi-asserted-by":"crossref","unstructured":"Carreras E, Diaz-Ricart M, Jodele S, Penack O, Vasu S. Early Complications of Endothelial Origin. In: Sureda A, Corbacioglu S, Greco R, Kr\u00f6ger N, Carreras E (eds). The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies. Springer International Publishing: Cham, 2024, pp 373\u201383.","DOI":"10.1007\/978-3-031-44080-9_42"},{"key":"2489_CR24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/bloodadvances.2019032268","volume":"3","author":"R Shouval","year":"2019","unstructured":"Shouval R, Fein JA, Shouval A, Danylesko I, Shem-Tov N, Zlotnik M, et al. External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation. Blood Adv. 2019;3:1881\u201390.","journal-title":"Blood Adv"},{"key":"2489_CR25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/bmt.2015.52","volume":"50","author":"M Mohty","year":"2015","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transpl. 2015;50:781\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"2489_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-023-00438-1","volume":"9","author":"F Malard","year":"2023","unstructured":"Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Acute graft-versus-host disease. Nat Rev Dis Prim. 2023;9:27.","journal-title":"Nat Rev Dis Prim"},{"key":"2489_CR27","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/j.bbmt.2018.06.013","volume":"24","author":"C Strouse","year":"2018","unstructured":"Strouse C, Zhang Y, Zhang M-J, DiGilio A, Pasquini M, Horowitz MM, et al. Risk score for the development of veno-occlusive disease after allogeneic hematopoietic cell transplant. Biol Blood Marrow Transpl. 2018;24:2072\u201380.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2489_CR28","doi-asserted-by":"publisher","unstructured":"Escribano-Serrat S, Rodr\u00edguez-Lobato LG, Su\u00e1rez-Lled\u00f3 M, Pedraza A, Charry P, Cid J, et al. Improving the EASIX\u2019 predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2024. https:\/\/doi.org\/10.1038\/s41409-024-02267-6.","DOI":"10.1038\/s41409-024-02267-6"},{"key":"2489_CR29","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1182\/bloodadvances.2020003885","volume":"5","author":"M Pennisi","year":"2021","unstructured":"Pennisi M, Sanchez-Escamilla M, Flynn JR, Shouval R, Alarcon Tomas A, Silverberg ML, et al. Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood Adv. 2021;5:3397\u2013406.","journal-title":"Blood Adv"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02489-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02489-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02489-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:02:56Z","timestamp":1741633376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02489-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1038\/s41409-024-02489-8","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}